Home Compare GRF.MC vs NOVO-B.CO
Stock Comparison · Industry comparison · Drug Manufacturers - General

Grifols vs Novo Nordisk A/S: Which Stock Looks Stronger in 2026?

Novo Nordisk A/S holds the cleaner structural position, with the lead spread across profitability and growth. Grifols, does not offset that deficit through any equally strong structural edge elsewhere. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the STOXX 600 universe, making them directly comparable.

Updated 2026-05-17

This is not just a one-metric split: both profitability and growth materially support the lead. Novo Nordisk A/S leads by 28 points on the overall comparison score.

INDUSTRY COMPARISON

Both operate in: Drug Manufacturers - General

This comparison is based on industry proximity, not on functional trajectory similarity. GRF.MC and NOVO-B.CO share the same industry classification.

For a similarity-based comparison, see how Grifols, and Novo Nordisk A/S each position within their functional peer groups in AssetNext.

Peer-Relative Score
GRF.MC
Grifols, S.A.
49
Peer-Score
Signal qualitylow
Peer basis: STOXX 600
vs
NOVO-B.CO
Novo Nordisk A/S
77
Peer-Score
Signal qualitylow
Peer basis: STOXX 600

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: GRF.MC vs NOVO-B.CO Profitability 44 91 Stability 13 34 Valuation 78 88 Growth 50 80 GRF.MC NOVO-B.CO
Gap Ranking
#1 Profitability +47
#2 Growth +30
#3 Stability +21
#4 Valuation +10
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for GRF.MC and NOVO-B.CO Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer GRF.MCNOVO-B.CO Relative valuation Structural strength

Novo Nordisk A/S looks stronger both structurally and on relative valuation.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Entry today — historical context

Where GRF.MC and NOVO-B.CO each sit in their own 5-year price and valuation history.

BASED ON 5-YEAR HISTORY GRF.MC Lower · below norm 0th 50th 100th 4 pct gap NOVO-B.CO Lower · below norm 0th 50th 100th 20th 16th
GRF.MC (20th percentile) and NOVO-B.CO (16th percentile) both sit in the lower portion of their own 5-year ranges. The historical entry context is broadly similar for both. This reflects entry timing, not which company is structurally stronger.

Describes historical entry positioning only. Descriptive — not investment advice.

Relative Position vs Comparable Companies
Profitability
Both rank well on profitability, but Novo Nordisk A/S still holds a clear edge.
Growth
On growth, the edge is clear — both rank well, but Novo Nordisk A/S sits noticeably higher.
Profitability — Dominant Gap
GRF.MC
44
NOVO-B.CO
91
Gap+47in favour of NOVO-B.CO

The profitability lead is mainly driven by a 45-point operating margin advantage.

What keeps the gap from being one-sided

Grifols, S.A. still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.

What this means for the comparison

The lead is built on both profitability and growth, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the GRF.MC vs NOVO-B.CO comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar profitability-and-growth comparisons

Explore how GRF.MC and NOVO-B.CO each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.